Hemo Organic share price today, results and news
Hemo Organic closed at ₹20.99 on 2 Nov 2026, down 3.94% on the day. It is 14.0% below its 52-week high of ₹24.42 and 151.1% above its 52-week low of ₹8.36. Over the past three months the share price has risen 84.1%.
At a glance
- Previous close
- ₹21.85
- Open
- ₹21.85
- Day’s range
- ₹20.76 – 21.85
- Volume
- 15,840
Last closing price. Updated after each trading day.
Earnings
Hemo Organic quarterly results and earnings call
Latest results
Upcoming results
SEBI’s listing rules give companies 45 days after a quarter ends to publish results (60 days for the full year). The exact board-meeting date is announced to the stock exchanges beforehand.
Latest earnings call
Companies usually hold the call on the day of their results or the day after, and post the recording and transcript on their website.
Find the latest transcript (opens in a new tab)5 things to know about Hemo Organic today
- Closed at ₹20.99 on 2 Nov 2026, down 3.94% on the day.
- Trades 14.0% below its 52-week high of ₹24.42 (14 Jul 2026) and 151.1% above its 52-week low of ₹8.36.
- Up 84.1% over three months, against +4.56% for the Nifty 50.
- 15,840 shares traded in the last session, 0.7× the 20-day average.
Share price vs Nifty 50
| Period | HEMORGANIC | Nifty 50 |
|---|---|---|
| 1 month | −5.75% | +10.35% |
| 3 months | +84.12% | +4.56% |
| Share price (₹) | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | Q3 FY27 (to date) |
|---|---|---|---|---|---|---|
| Closing price | 9.50 | 17.18 | 11.70 | 21.11 | 21.88 | 20.99 |
| Change QoQ | −11.13% | +80.84% | −31.90% | +80.43% | +3.65% | −4.07% |
| High | 11.84 | 22.51 | 18.57 | 22.29 | 24.42 | 22.97 |
| Low | 8.08 | 8.12 | 11.70 | 9.71 | 17.97 | 20.76 |
| Share price (₹) | FY24 | FY25 | FY26 | FY27 (to date) |
|---|---|---|---|---|
| Closing price | 10.20 | 8.97 | 11.70 | 20.99 |
| Change YoY | — | −12.06% | +30.43% | +79.40% |
| High | 10.41 | 15.25 | 22.51 | 24.42 |
| Low | 5.57 | 8.05 | 8.08 | 9.71 |
Share price by quarter and financial year from closing prices. The reported revenue, profit and EPS of Hemo Organic will replace this table once added from the company’s results.
Technical indicators
Hemo Organic technical indicators
Calculated from daily closing prices up to 2 Nov 2026. They describe past prices only and are not a forecast.
RSI compares recent gains with recent losses on a 0 to 100 scale. Readings above 70 are commonly described as overbought and below 30 as oversold.
The MACD line is below its 9-day signal line (1.05). MACD tracks the gap between the 12-day and 26-day exponential averages.
The close is 3.2% below the average closing price of the last 20 trading days.
The close is 15.5% above the average closing price of the last 50 trading days.
The close is 79% of the way from the 52-week low (₹8.36, 4 Nov 2025) to the high (₹24.42, 14 Jul 2026).
15,840 shares traded in the last session, against a 20-day average of 21,707.
FAQ
Questions about Hemo Organic
What is the share price of Hemo Organic today?
Hemo Organic closed at ₹20.99 on 2 Nov 2026, down 3.94% from the previous close of ₹21.85 on the BSE.
What is the 52-week high and low of Hemo Organic?
In the last 52 weeks Hemo Organic traded between a low of ₹8.36 on 4 Nov 2025 and a high of ₹24.42 on 14 Jul 2026. The last close is 14.0% below the high.
How has Hemo Organic stock performed recently?
Based on closing prices up to 2 Nov 2026, Hemo Organic shares are down 5.7% over one month, up 84.1% over three months.
What is the stock symbol and ISIN of Hemo Organic?
Hemo Organic is listed on the BSE under the symbol HEMORGANIC. Its ISIN is INE422G01015.
About this data
- Prices and indicators: last closing prices, updated 2 Nov 2026, 7:23 pm IST.
- Headlines: linked to the publisher that reported them. We store only the headline, link and date.
Disclaimer: Marketasset is an information service and is not registered with SEBI as an investment adviser or research analyst. We do not publish our own analysis or ratings of any stock. Prices are the last closing prices, technical indicators are calculated from past prices, headlines link to the original publisher and company figures come from the company’s own published documents. Nothing here is a recommendation to buy, sell or hold any security.